Cargando…

Morphological Changes and Prognostic Factors before and after Photodynamic Therapy for Central Serous Chorioretinopathy

Central serous chorioretinopathy (CSC) is a disease of unknown etiology, but half-dose photodynamic therapy (hPDT) is well known to be effective for CSC. Infrared reflectance (IR) has been shown to be effective for detecting retinal pigmented epithelial and choroidal lesions, but no reports have foc...

Descripción completa

Detalles Bibliográficos
Autores principales: Wakatsuki, Yu, Tanaka, Koji, Mori, Ryusaburo, Furuya, Koichi, Kawamura, Akiyuki, Nakashizuka, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827861/
https://www.ncbi.nlm.nih.gov/pubmed/33440827
http://dx.doi.org/10.3390/ph14010053
_version_ 1783640870349701120
author Wakatsuki, Yu
Tanaka, Koji
Mori, Ryusaburo
Furuya, Koichi
Kawamura, Akiyuki
Nakashizuka, Hiroyuki
author_facet Wakatsuki, Yu
Tanaka, Koji
Mori, Ryusaburo
Furuya, Koichi
Kawamura, Akiyuki
Nakashizuka, Hiroyuki
author_sort Wakatsuki, Yu
collection PubMed
description Central serous chorioretinopathy (CSC) is a disease of unknown etiology, but half-dose photodynamic therapy (hPDT) is well known to be effective for CSC. Infrared reflectance (IR) has been shown to be effective for detecting retinal pigmented epithelial and choroidal lesions, but no reports have focused on chorioretinal changes using IR images after as compared to before hPDT. This study aimed to clarify the features of IR images as well as retinal and choroidal morphological changes before and after treatment with verteporfin hPDT for CSC. We also examined prognostic factors associated with CSC treatment. This was a retrospective study that included 140 eyes of 140 patients (male/female ratio 122:18, mean age 53.4 ± 10.8 years) diagnosed with CSC who underwent hPDT in our hospital during the period from April 2015 to December 2018. We determined changes in visual acuity, therapeutic efficacy, central retinal thickness (CRT), central choroidal thickness (CCT), and IR images at one and three months after hPDT as compared to before treatment. Dry macula was defined as a complete resolution of serous retinal detachment after hPDT. History of smoking, disease duration, presence of drusen, presence of retinal pigment epithelium abnormalities, type of fluorescein angiographic leakage, and presence of choroidal vascular hyperpermeability were investigated as prognostic factors associated with treatment efficacy. CRT and CCT were measured using optical coherence tomography (Spectralis HRA-2; Heidelberg Engineering), and IR images after versus before treatment were compared using ImageJ software (version 1.52) to calculate the mean luminance for a 3 × 3 mm area in the macula. Compared with the values before treatment, CCT, CRT, and visual acuity showed significant improvements at one and three months after treatment, and the mean luminance of IR images was also significantly increased. Furthermore, the luminance on IR images tended to rise, though the values at one month and three months after treatment did not differ significantly. Disease duration was significantly associated with dry macula one month after treatment, and visual acuity and CRT before hPDT were both significantly related to dry macula three months after treatment. IR images tended to improve over time, from before treatment through one and three months after hPDT.
format Online
Article
Text
id pubmed-7827861
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-78278612021-01-25 Morphological Changes and Prognostic Factors before and after Photodynamic Therapy for Central Serous Chorioretinopathy Wakatsuki, Yu Tanaka, Koji Mori, Ryusaburo Furuya, Koichi Kawamura, Akiyuki Nakashizuka, Hiroyuki Pharmaceuticals (Basel) Article Central serous chorioretinopathy (CSC) is a disease of unknown etiology, but half-dose photodynamic therapy (hPDT) is well known to be effective for CSC. Infrared reflectance (IR) has been shown to be effective for detecting retinal pigmented epithelial and choroidal lesions, but no reports have focused on chorioretinal changes using IR images after as compared to before hPDT. This study aimed to clarify the features of IR images as well as retinal and choroidal morphological changes before and after treatment with verteporfin hPDT for CSC. We also examined prognostic factors associated with CSC treatment. This was a retrospective study that included 140 eyes of 140 patients (male/female ratio 122:18, mean age 53.4 ± 10.8 years) diagnosed with CSC who underwent hPDT in our hospital during the period from April 2015 to December 2018. We determined changes in visual acuity, therapeutic efficacy, central retinal thickness (CRT), central choroidal thickness (CCT), and IR images at one and three months after hPDT as compared to before treatment. Dry macula was defined as a complete resolution of serous retinal detachment after hPDT. History of smoking, disease duration, presence of drusen, presence of retinal pigment epithelium abnormalities, type of fluorescein angiographic leakage, and presence of choroidal vascular hyperpermeability were investigated as prognostic factors associated with treatment efficacy. CRT and CCT were measured using optical coherence tomography (Spectralis HRA-2; Heidelberg Engineering), and IR images after versus before treatment were compared using ImageJ software (version 1.52) to calculate the mean luminance for a 3 × 3 mm area in the macula. Compared with the values before treatment, CCT, CRT, and visual acuity showed significant improvements at one and three months after treatment, and the mean luminance of IR images was also significantly increased. Furthermore, the luminance on IR images tended to rise, though the values at one month and three months after treatment did not differ significantly. Disease duration was significantly associated with dry macula one month after treatment, and visual acuity and CRT before hPDT were both significantly related to dry macula three months after treatment. IR images tended to improve over time, from before treatment through one and three months after hPDT. MDPI 2021-01-11 /pmc/articles/PMC7827861/ /pubmed/33440827 http://dx.doi.org/10.3390/ph14010053 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Wakatsuki, Yu
Tanaka, Koji
Mori, Ryusaburo
Furuya, Koichi
Kawamura, Akiyuki
Nakashizuka, Hiroyuki
Morphological Changes and Prognostic Factors before and after Photodynamic Therapy for Central Serous Chorioretinopathy
title Morphological Changes and Prognostic Factors before and after Photodynamic Therapy for Central Serous Chorioretinopathy
title_full Morphological Changes and Prognostic Factors before and after Photodynamic Therapy for Central Serous Chorioretinopathy
title_fullStr Morphological Changes and Prognostic Factors before and after Photodynamic Therapy for Central Serous Chorioretinopathy
title_full_unstemmed Morphological Changes and Prognostic Factors before and after Photodynamic Therapy for Central Serous Chorioretinopathy
title_short Morphological Changes and Prognostic Factors before and after Photodynamic Therapy for Central Serous Chorioretinopathy
title_sort morphological changes and prognostic factors before and after photodynamic therapy for central serous chorioretinopathy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827861/
https://www.ncbi.nlm.nih.gov/pubmed/33440827
http://dx.doi.org/10.3390/ph14010053
work_keys_str_mv AT wakatsukiyu morphologicalchangesandprognosticfactorsbeforeandafterphotodynamictherapyforcentralserouschorioretinopathy
AT tanakakoji morphologicalchangesandprognosticfactorsbeforeandafterphotodynamictherapyforcentralserouschorioretinopathy
AT moriryusaburo morphologicalchangesandprognosticfactorsbeforeandafterphotodynamictherapyforcentralserouschorioretinopathy
AT furuyakoichi morphologicalchangesandprognosticfactorsbeforeandafterphotodynamictherapyforcentralserouschorioretinopathy
AT kawamuraakiyuki morphologicalchangesandprognosticfactorsbeforeandafterphotodynamictherapyforcentralserouschorioretinopathy
AT nakashizukahiroyuki morphologicalchangesandprognosticfactorsbeforeandafterphotodynamictherapyforcentralserouschorioretinopathy